Riskpilot
← Back to search
Sign in
Get full access
DIABBLOM AB
AB
Active
Org 5593446841
Taptogränd 8, 831 49
Östersund
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
DIABBLOM AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
155
147
316
Staff expenses
−2
—
−4
EBITDA
130
109
240
Depreciation & amort.
—
−0
—
EBIT
130
109
240
Net financials
0
2
−0
Profit before tax
130
111
240
Tax
−27
−23
−49
Net profit
103
88
190
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
130
131
271
Equity
128
116
227
Long-term debt
—
0
—
Short-term debt
2
15
45
Total debt
2
15
45
Financial ratios
5-year trend
EBITDA margin
76.0%
This company
15.8%
Market median
+381% vs market
2023
2025
Equity ratio
83.6%
This company
38.2%
Market median
+119% vs market
2023
2025
Return on equity
84.0%
This company
18.4%
Market median
+357% vs market
2023
2025
Net profit margin
60.3%
This company
8.1%
Market median
+644% vs market
2023
2025
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
2023
2025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2021-11-04 – 2023-04-30
View
PDF